05/02/2024
8:00 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/26/2024
4:15 PM | Moleculin Biotech (Filer)
| Form 10-K/A | |
04/25/2024
7:23 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/18/2024
7:30 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/10/2024
7:30 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/10/2024
7:30 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/08/2024
4:14 PM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
03/27/2024
8:05 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2024
2:03 PM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2024
6:30 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/20/2024
6:30 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/19/2024
3:31 PM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/29/2024
7:30 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/22/2024
8:30 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/16/2024
4:19 PM | Moleculin Biotech (Filer)
| Form 424B3 | |
02/15/2024
8:15 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
3:36 PM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
2:43 PM | ARMISTICE CAPITAL, LLC (Filed by)
Moleculin Biotech (Subject)
| Form SC 13G | |
02/12/2024
11:15 PM | Moleculin Biotech (Filer)
| Form EFFECT | |
02/02/2024
4:05 PM | Moleculin Biotech (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
01/24/2024
7:50 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/05/2024
4:14 PM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/05/2024
4:15 PM | Moleculin Biotech (Filer)
| Form PRE 14A | |
12/27/2023
6:31 AM | KLEMP WALTER V (Reporting)
Moleculin Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2023
6:31 AM | George Robert E. (Reporting)
Moleculin Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2023
6:32 AM | Foster Jonathan P. (Reporting)
Moleculin Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/22/2023
4:00 PM | Moleculin Biotech (Filer)
| Form 424B5 | |
12/21/2023
4:17 PM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2023
7:55 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/11/2023
7:55 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/11/2023
7:50 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/20/2023
8:15 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2023
7:30 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2023
7:05 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2023
7:00 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2023
7:00 AM | Moleculin Biotech (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2023
7:45 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2023
7:35 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2023
8:00 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/06/2023
4:15 PM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/02/2023
7:40 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Is Tesla going out of business? (Ad) Goldman Sachs estimates that this new “Future Fuel” will unleash an $11.7 trillion wave of wealth over the coming decade.
That’s 10 TIMES BIGGER than the electric vehicle market.  Click here for the full story |
09/21/2023
7:50 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/18/2023
7:40 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/14/2023
7:35 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/21/2023
4:12 PM | Moleculin Biotech (Filer)
| Form PRE 14A | |
08/21/2023
4:17 PM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/21/2023
6:30 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/11/2023
6:00 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2023
7:40 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/03/2023
7:45 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/13/2023
5:35 PM | KLEMP WALTER V (Reporting)
Moleculin Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/13/2023
7:40 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/26/2023
5:19 PM | Moleculin Biotech (Issuer)
PICKER DONALD H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
5:20 PM | KLEMP WALTER V (Reporting)
Moleculin Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
5:21 PM | Foster Jonathan P. (Reporting)
Moleculin Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2023
6:00 PM | KLEMP WALTER V (Reporting)
Moleculin Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2023
6:02 PM | Foster Jonathan P. (Reporting)
Moleculin Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2023
6:03 PM | Moleculin Biotech (Issuer)
PICKER DONALD H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
4:16 PM | Moleculin Biotech (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/20/2023
5:00 PM | KLEMP WALTER V (Reporting)
Moleculin Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
5:00 PM | Foster Jonathan P. (Reporting)
Moleculin Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
7:35 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2023
4:00 PM | Moleculin Biotech (Filer)
| Form DEFA14A | |
05/30/2023
6:48 AM | Moleculin Biotech (Filer)
| Form DEFA14A | |
05/26/2023
4:15 PM | George Robert E. (Reporting)
Moleculin Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/26/2023
4:15 PM | CANNON MICHAEL D (Reporting)
Moleculin Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/26/2023
4:16 PM | Climaco John M (Reporting)
Moleculin Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/26/2023
4:16 PM | Cermak Elizabeth (Reporting)
Moleculin Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/26/2023
4:16 PM | Moleculin Biotech (Issuer)
Yan Joy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/26/2023
6:37 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/11/2023
6:05 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2023
3:05 PM | Moleculin Biotech (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/10/2023
3:07 PM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
